Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives

Clinical evidence suggests that nebulized colistimethate sodium (CMS) has benefits for treating lower respiratory tract infections caused by multidrug-resistant Gram-negative bacteria (GNB). Colistin is positively charged, while CMS is negatively charged, and both have a high molecular mass and are...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yinggang Zhu, Antoine Monsel, Jason A. Roberts, Konstantinos Pontikis, Olivier Mimoz, Jordi Rello, Jieming Qu, Jean-Jacques Rouby, on behalf of the European Investigator Network for Nebulized Antibiotics in Ventilator-Associated Pneumonia (ENAVAP)
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2021-05-01
Schriftenreihe:	Microorganisms
Schlagworte:	nebulized polymyxin nebulized colistimethate sodium colistin multidrug resistant gram-negative bacteria ventilator-associated pneumonia ventilator-associated tracheobronchitis
Online-Zugang:	https://www.mdpi.com/2076-2607/9/6/1154
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!